BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23095431)

  • 1. Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.
    Oyer D; Niemeyer M; Moses A
    Postgrad Med; 2012 Sep; 124(5):110-20. PubMed ID: 23095431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pens: the modern delivery devices.
    Baruah MP
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T; Campos C
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
    Nadeau DA; Campos C; Niemeyer M; Bailey T
    Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.
    Bastian MD; Wolters NE; Bright DR
    Consult Pharm; 2011 Jun; 26(6):426-9. PubMed ID: 21628141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing barriers to insulin therapy: the role of insulin pens.
    Magwire ML
    Am J Ther; 2011 Sep; 18(5):392-402. PubMed ID: 20838202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of insulin pen devices.
    McCoy EK; Wright BM
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals.
    Bailey T; Thurman J; Niemeyer M; Schmeisl G
    Curr Med Res Opin; 2011 Oct; 27(10):2043-52. PubMed ID: 21916529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurse satisfaction using insulin pens in hospitalized patients.
    Davis EM; Bebee A; Crawford L; Destache C
    Diabetes Educ; 2009; 35(5):799-809. PubMed ID: 19633151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use.
    Cornell S
    Health Policy; 2010 Aug; 96(3):191-9. PubMed ID: 20226560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.
    Davis EM; Christensen CM; Nystrom KK; Foral PA; Destache C
    Am J Health Syst Pharm; 2008 Jul; 65(14):1347-57. PubMed ID: 18593681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.